| 摘要 |
The present invention relates to methods of treating diseases or disorders affecting the eye or optic nerve characterised by elevated &bgr;-amyloid levels or &bgr;-amyloid deposits, particularly age related macular degeneration and glaucoma type diseases and &bgr;-amyloid dependent cataract formation, with antigen binding proteins that bind &bgr;-amyloid peptide and in particular human &bgr;-amyloid peptide.
|
